MedTrace Logo

Late Night Snack and Insulin Glargine

NCT02871180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-08-18

No results posted yet for this study

Summary

Twenty patient with Type 1 diabetes, using insulin glargine as basal insulin, participated in a prospective, controlled crossover trial comparing blood glucose profiles over two 24 h periods with and without a late night snack (a slice of rye bread, 20 g carbohydrates, at 10 p.m.), in randomized order. The main endpoint was the number of hypoglycemic episodes with a confirmed laboratory blood glucose ≤ 50 mg/dl between 10 p.m. and 8 p.m. the following day. Secondary endpoint was the blood glucose profile during this period.

Conditions

Interventions

DIETARY_SUPPLEMENT

Late night snack

The late night snack was one slice of whole meal rye bread containing approximately 20 g of carbohydrate.

OTHER

No late night snack

Patient consumed no nutrients at late night.

Sponsors & Collaborators

  • Diabeteszentrum Bad Lauterberg im Harz

    lead OTHER

Principal Investigators

  • Michael A. Nauck, Prof. · St. Josef-Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2016-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02871180 on ClinicalTrials.gov